Lexaria Bioscience Corp. (LEXX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.84M |
| Enterprise Value | 14.15M |
| P/E Ratio | -0.58 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 26.32 |
| Price/Book Ratio | 1.08 |
| Enterprise/Revenue | 8.86 |
| Enterprise/EBITDA | -0.22 |
Fiscal Year
| Fiscal Year | August 31, 2025 |
| Most Recent Quarter | May 31, 2026 |
Profitability
| Profit Margin | -39.86 |
| Operating Margin | -39.73 |
AD
Management Effectiveness
| Return On Assets | -1.62 |
| Return On Equity | -1.61 |
Income Statement
| Revenue | 705,923 |
| Revenue/Share | 0.12 |
| Gross Profit | 703,203 |
| EBITDA | -11.82M |
| Net Income | -11.9M |
| Diluted EPS | -9.9 |
Balance Sheet
| Total Cash | 3.62M |
| Total Cash/Share | 2.19 |
| Total Debt | 86,714 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 10.6 |
| Book Value Per Share | 2.63 |
Price History
| 52-Week Change | -78.88 |
| 52-Week High | 21.6 |
| 52-Week Low | 2.8 |
| Moving Average 50 Days | 7.26 |
| Moving Average 200 Days | 9.8 |
Statistics
| Average Volume | 58,409 |
| Shares Outstanding | 1.65M |
| % Held by Institutions | 6.61 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | August 03, 2026 |
AD
